Patient follow-up after treatment for breast cancer

被引：0
作者：
Classe, J. -M. [1 ]
Sentilhes, L. [2 ]
Jaffre, I. [1 ]
Mezzadri, M. [2 ]
Lefebvre-Lacoeuille, C. [2 ]
Dejode, M. [1 ]
Catala, L. [2 ]
Bordes, V. [1 ]
Dravet, F. [1 ]
Descamps, P. [2 ]
机构：
[1] Inst Cancerol Nantes Atlantique, Ctr Lutte Canc CLCC Rene Gauducheau, Serv Chirurg Oncol, F-44805 Nantes, France
[2] CHU Angers, F-49033 Angers 1, France
来源：
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2010年 / 39卷 / 08期
关键词：
Breast cancer; Follow-up; TUMOR-MARKERS; METASTASES; PHENOTYPE; RECURRENCE; CARCINOMA; PATTERNS; SURVIVAL; DISEASE;
D O I：
10.1016/j.jgyn.2010.10.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Patient follow-up after treatment for a breast cancer is based on the local recurrence risk. Annual mammography remains the main point of this follow-up and tumor markers detection has still no interest. Absence of benefit of an intensive clinical, biological and radiological surveillance has been proved for a long time but expert recommendations still are a subject of discussion although they knew no evolution for more than 10 years. Evolution of those follow-up modalities will depend on the future indications of MRI and PET. About distant recurrence, a better knowledge of the risk is now possible thanks to the tumor biological profile study. Nevertheless, intensification of follow-up for some kind of high-risk tumors will have interest only if we can propose a therapeutic alternative in metastatic situation. (C) 2010 Published by Elsevier Masson SAS.
引用
收藏
页码：F85 / F88
页数：4
相关论文
共 34 条
[1]  
Agence nationale d'accreditation et d'evaluation en sante, 1999, CANC SEIN, P27
[2]   Spectrum of breast cancer metastasis in BRCA1 mutation carriers:: highly increased incidence of brain metastases [J].
Albiges, L ;
André, F ;
Balleyguier, C ;
Gomez-Abuin, G ;
Chompret, A ;
Delaloge, S .
ANNALS OF ONCOLOGY, 2005, 16 (11) :1846-U3
[3]  
[Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001768.PUB2
[4]   Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J].
Banerjee, S. ;
Reis-Filho, J. S. ;
Ashley, S. ;
Steele, D. ;
Ashworth, A. ;
Lakhani, S. R. ;
Smith, I. E. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (07) :729-735
[5]   Surveillance mammography following the treatment of primary breast cancer with breast reconstruction: A systematic review [J].
Barnsley, G. Philip ;
Grunfeld, Eva ;
Coyle, Douglas ;
Paszat, Lawrence .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2007, 120 (05) :1125-1132
[6]  
Boekhorst DST, 2001, EUR J SURG, V167, P490
[7]   Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer [J].
Burzykowski, Tomasz ;
Buyse, Marc ;
Piccart-Gebhart, Martine J. ;
Sledge, George ;
Carmichael, James ;
Lueck, Hans-Joachim ;
Mackey, John R. ;
Nabholtz, Jean-Marc ;
Paridaens, Robert ;
Biganzoli, Laura ;
Jassem, Jacek ;
Bontenbal, Marijke ;
Bonneterre, Jacques ;
Chan, Stephen ;
Basaran, Gul Atalay ;
Therasse, Patrick .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :1987-1992
[8]  
CLAVIEN PA, 1990, EUR J SURG ONCOL, V16, P121
[9]   INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL [J].
DELTURCO, MR ;
PALLI, D ;
CARIDDI, A ;
CIATTO, S ;
PACINI, P ;
DISTANTE, V ;
AZZINI, V ;
BELSANTI, V ;
BARTOLUCCI, R ;
DICOSTANZO, F ;
BERTUSI, M ;
DANESE, S ;
GIARDINA, G ;
DAIUTO, G ;
UCCELLO, V ;
DELEO, G ;
PUNZO, C ;
GOSSO, P ;
GRISO, C ;
LOCATELLI, E ;
MANSUTTI, M ;
SANDRI, P ;
MOLINO, AM ;
SCHINCAGLIA, P ;
TIENGHI, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20) :1593-1597
[10]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
1234